Stem Cell Transplantation

Stem-cell Transplantation May Improve Overall Survival of Patients With Relapsed MM

Stem-cell Transplantation May Improve Overall Survival of Patients With Relapsed MM

By

Salvage autologous stem-cell transplantation (ASCT) may improve overall survival (OS) of patients with relapsed multiple myeloma treated with an initial ASCT.

Inotuzumab Ozogamicin May Improve Survival for Patients With Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin May Improve Survival for Patients With Acute Lymphoblastic Leukemia

By

Patients with ALL treated with the monoclonal antibody inotuzumab ozogamicin were more likely to proceed to stem cell transplantation.

Bendamustine, Gemcitabine, Vinorelbine Promising Treatment for Relapsed or Refractory Hodgkin Lymphoma

Bendamustine, Gemcitabine, Vinorelbine Promising Treatment for Relapsed or Refractory Hodgkin Lymphoma

By

BeGEV appears to provide clinical benefit for patients with relapsed or refractory Hodgkin lymphoma, and ought to be developed further.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs